Selected Disorders of the Genitourinary System

  • John L. Pfenninger
  • Grant C. Fowler
  • Robert E. James


Urinary incontinence afflicts an estimated 13 million Americans of all ages with adverse psychological, physical, social, and financial consequences. Falls, fractures, pressure sores, urinary tract infections, urosepsis, sexual dysfunction, and depression have all been associated with urinary incontinence. An estimated $15 billion is spent annually on incontinence.1 Among the most adverse psychosocial consequences, urinary incontinence can disrupt a family because it is one of the most common reasons for institutionalizing a family member. Even for noninstitu-tionalized individuals, urinary incontinence has been severely underreported, cases underevaluated, and medical services underutilized. It is especially unfortunate because more than 90% of cases can be improved or cured, often with medical management alone.2


Bladder Cancer Urinary Incontinence Stress Urinary Incontinence Human Papilloma Virus Calcium Oxalate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Urinary Incontinence Guideline Panel. Clinical practice guideline; urinary incontinence in adults: acute and chronic management. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1996. No. 2, 1996 Update.Google Scholar
  2. 2.
    Retzky SS, Rogers RM. Urinary incontinence in women. Clin Symp 1995;47:2–32.PubMedGoogle Scholar
  3. 3.
    Mobley D, Goldberg K, Wilson S. Management of urinary incontinence. Geriatr Med Today 1991;110:18–32.Google Scholar
  4. 4.
    Jeter KF, Wagner DB. Incontinence in the American home: a survey of 36,500 people. J Am Geriatr Soc 1990;30:379–83.Google Scholar
  5. 5.
    Resnick NM. Initial evaluation of the incontinent patient. J Am Geriatr Soc 1990;38:311–6.PubMedGoogle Scholar
  6. 6.
    Fowler GC, Ryan JG, Duiker SS. Evaluating and treating urinary incontinence. Female Patient 1993;18:63–78.Google Scholar
  7. 7.
    Rousseau P, Fuentevilla-Clifton A. Urinary incontinence in the aged. Part 1. Patient evaluation. Geriatrics 1992;47(6): 22–34.PubMedGoogle Scholar
  8. 8.
    Urinary incontinence. Washington, DC: ACOG, 1995. ACOG Technical Bulletin no. 213.Google Scholar
  9. 9.
    Walters MD, Realini JP. The evaluation and treatment of urinary incontinence in women: a primary care approach. J Am Board Fam Pract 1992;5:289–300.PubMedGoogle Scholar
  10. 10.
    Ramsey SD, Wagner TH, Bavendam TG. Estimated costs of treating stress urinary incontinence in elderly women according to the AHCPR clinical practice guidelines. Am J Managed Care 1996;2:147–54.Google Scholar
  11. 11.
    Waxman S, Webster GD. Advanced urologie surgery for urinary incontinence. Female Patient 1996;21:93–100.Google Scholar
  12. 12.
    Resnick NM, Blaivas JG, Ostergard DR. Practical pointers on urinary incontinence. Patient Care 1995;29:103–35.Google Scholar
  13. 13.
    Derksen DJ, Smith AY. Benign conditions of the external genitalia. Prim Care 1989;16:981–95.PubMedGoogle Scholar
  14. 14.
    Bullock N, Sibley G. Essential urology. 2nd ed. Edinburgh: Churchill Livingstone, 1994.Google Scholar
  15. 15.
    McGuire EJ, Bloom D, Catalona WJ, Lipshultz LI. Advances in urology, vol. 8. St. Louis: Mosby, 1995.Google Scholar
  16. 16.
    Blandy J, Fowler C. Urology. 2nd ed. Oxford: Blackwell, 1996.Google Scholar
  17. 17.
    MacFarlane MT. Urology. 2nd ed. Baltimore: Williams & Wil-kins, 1995.Google Scholar
  18. 18.
    Steckel J, Dicker AP, Goldstein M. Relationship between varicocele size and response to varicocelectomy. J Urol 1993;149: 769–71.PubMedGoogle Scholar
  19. 19.
    Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5–27.PubMedCrossRefGoogle Scholar
  20. 20.
    Lamm DL, Torti FM. Bladder cancer, 1996. CA Cancer J Clin 1996;46:93–112.PubMedCrossRefGoogle Scholar
  21. 21.
    Normura A, Kolonel LN, Yoshizawa CN. Smoking, alcohol, occupation and hair dye use in cancer of the lower urinary tract. Am J Epidemiol 1989;130:1159–66.Google Scholar
  22. 22.
    Cantor KP, Hoover R, Hartge P, et al. Bladder cancer, drinking water source, and tap water consumption: a case study. J Natl Cancer Inst 1987;79:1269.PubMedGoogle Scholar
  23. 23.
    Lopez-Beltran A, Munoz E. Transitional cell carcinoma of the bladder: low incidence of human papillomavirus DNA detected by the polymerase chain reaction and in situ hybridization. Histopathology 1995;26:565–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Mvula M, Iwasaka T, Iguchi A, Nakamura S, Masaki Z, Sugimori H. Do human papillomaviruses have a role in the pathogenesis of bladder carcinoma? J Urol 1996;155:471–4.PubMedCrossRefGoogle Scholar
  25. 25.
    Lopez-Beltran A, Munoz E. Human papillomavirus DNA as a factor determining the survival of bladder cancer patients. Br J Cancer 1996;73:124–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Mettlin C, Dodd GD. The American Cancer Society guidelines for the cancer-related check up: an update. CA Cancer J Clin 1991;41:279–82.PubMedCrossRefGoogle Scholar
  27. 27.
    Screening for bladder cancer. In: The US Preventive Services Task Force: guide to clinical preventive services. 2nd ed. Baltimore: Williams & Wilkins, 1996:181–6.Google Scholar
  28. 28.
    D’Hallewin MA, Baert L. Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J Urol 1996; 155:475–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Sarosdy MF, DeVere White RW, Soloway MS, et al. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 1995;154:379–84.PubMedCrossRefGoogle Scholar
  30. 30.
    Badalament RA, Kimmel M, Gay H, et al. The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma. Cancer 1987;59: 2078–85.PubMedCrossRefGoogle Scholar
  31. 31.
    Klein FA, White FK. Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience. J Urol 1988;139:275–8.PubMedGoogle Scholar
  32. 32.
    Sutton JM. Evaluation of hematuria in adults. JAMA 1990; 263:2479–80.CrossRefGoogle Scholar
  33. 33.
    Herr HW, Badalament RA, Amato DA, et al. Superficial bladder cancer treated with BCG: a multivariate analysis of factors affecting tumor progression. J Urol 1989;141:146.Google Scholar
  34. 34.
    Hautmann RE, Pis T, de Petriconi R. Ileal bladder in women: nine years of experience with eighteen patients. J Urol 1966; 155:76–80.CrossRefGoogle Scholar
  35. 35.
    Normura A, Kolonel LN, Hankin JH, et al. Dietary factors in cancer of the lower urinary tract. Intl J Cancer 1991;48:199–204.CrossRefGoogle Scholar
  36. 36.
    Weinhouse S, Bai DG, Adamson R, et al. American Cancer Society guidelines on diet, nutrition, and cancer. CA Cancer J Clin 1991;41:334–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Lamm DL, Riggs DR, Shriver JS, et al. Megadose vitamins in bladder cancer: a double-blind clinical trial. J Urol 1994;151: 21–6.PubMedGoogle Scholar
  38. 38.
    LeRoy A. Diagnosis and treatment of nephrolithiasis: current perspective. AJR 1994;163:1309–13.PubMedCrossRefGoogle Scholar
  39. 39.
    Labrecque M, Dostaler DP, Rousselli R, et al. Efficacy of nonsteroidal antiinflammatory drugs in treatment of acute renal colic. Arch Intern Med 1994;154:1381–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Kupin WL. A practical approach to nephrolithiasis. Hosp Pract 1995:57–93.Google Scholar
  41. 41.
    Preminger GM. The metabolic evaluation of patients with recurrent nephrolithiasis: review of comprehensive and simplified approaches. J Urol 1989;141:760–8.PubMedGoogle Scholar
  42. 42.
    Levy FL. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 1995;98:50–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Hughes J, Norman RW. Diet and calcium stones. Can Med Assoc J 1992;146:137–43.Google Scholar
  44. 44.
    Preminger GM. Management of nephrolithiasis and ureteral lithiasis. Hosp Med 1991;27(l):22–50.Google Scholar
  45. 45.
    Lingamen JE, Newman DM, Metz JHO, et al. Extracorporeal shock wave lithotripsy: the Methodist Hospital of Indiana experience. J Urol 1986;135:1134.Google Scholar
  46. 46.
    James RE, Novick AN, Straffon RA, Stewart BH. Anatrophic nephrolithotomy for removal of staghorn or branch calculi. Urology 1980;15:108–111.PubMedCrossRefGoogle Scholar
  47. 47.
    Dayman RV, Bagley DH. Ureteral nephroscopy. In: Gillenwater GY, Grayhack JT, Howards S, Duckett JW, editors. Adult and pediatric urology. Chicago: Year Book, 1990.Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • John L. Pfenninger
  • Grant C. Fowler
  • Robert E. James

There are no affiliations available

Personalised recommendations